183 results on '"Cherry, Catherine L."'
Search Results
2. Psychological Factors Associated With Painful Versus Non-Painful HIV-Associated Sensory Neuropathy
3. A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial disease
4. Polymorphisms in CAMKK2 may predict sensory neuropathy in African HIV patients
5. The International Physical Activity Questionnaire Overestimates Moderate and Vigorous Physical Activity in HIV-Infected Individuals Compared With Accelerometry
6. HIV-Associated Sensory Neuropathy: Risk Factors and Genetics
7. Macrophage migration inhibitory factor: a potential biomarker for cardiovascular disease in persons with HIV?
8. TNF-block genotypes influence susceptibility to HIV-associated sensory neuropathy in Indonesians and South Africans
9. Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-infected individuals
10. Adverse effects of antiretroviral drugs on HIV-1-infected and -uninfected human monocyte-derived macrophages
11. Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from stavudine to abacavir or zidovudine
12. Polymorphisms in uncoupling protein genes UCP2 and UCP3 are not associated with HIV-associated sensory neuropathy in African individuals
13. Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat
14. HIV-associated sensory neuropathy: still a problem in the post-stavudine era?
15. Plasma levels of JC virus are sensitive and specific for detecting and predicting progressive multifocal leukoencephalopathy in HIV patients
16. A new way of measuring apoptosis by absolute quantitation of inter-nucleosomally fragmented genomic DNA
17. TNF-Block Genotypes Influence Susceptibility to HIV-Associated Sensory Neuropathy in Indonesians and South Africans
18. Ubisol-AquaTM: Coenzyme Q10 Prevents Antiretroviral Toxic Neuropathy in an In Vitro Model
19. Measuring and monitoring apoptosis and drug toxicity in HIV patients by ligation-mediated polymerase chain reaction
20. Phase 1 Single Dose Studies to Optimize the Pharmacokinetics of DG17, a Novel HIV-Protease Inhibitor Pro-Drug, Using Sodium Bicarbonate and Ritonavir
21. A six-month, supervised, aerobic and resistance exercise program improves self-efficacy in people with human immunodeficiency virus: A randomised controlled trial
22. Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine
23. Nucleoside analogues and HIV: the combined cost to mitochondria
24. HIV-associated sensory neuropathies
25. Assessment of precision and concordance of quantitative mitochondrial DNA assays: a collaborative international quality assurance study
26. Nucleoside analogues and neuropathy in the era of HAART
27. Clinical diagnosis of sensory neuropathy in HIV patients treated with tenofovir: A 6‐month follow‐up study
28. HIV-associated sensory neuropathy continues to be a problem in individuals starting tenofovir-based antiretroviral treatment
29. Producing an evidence‐based treatment information website in partnership with people affected by multiple sclerosis
30. Quantification of mitochondrial DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction
31. Demographic and Genetic Associations With Markers of Small and Large Fiber Sensory Neuropathy in HIV Patients Treated Without Stavudine.
32. Polymorphism rs1385129 Within Glut1 Gene SLC2A1 Is Linked to Poor CD4+ T Cell Recovery in Antiretroviral-Treated HIV+ Individuals
33. Producing an evidence-based treatment information website in partnership with people affected by multiple sclerosis
34. Consumer engagement critical to success in an Australian research project: reflections from those involved
35. A Longitudinal Study of the Effects of ART on Plasma Chemokine Levels in Malaysian HIV Patients
36. Immunometabolic and Lipidomic Markers Associated With the Frailty Index and Quality of Life in Aging HIV+ Men on Antiretroviral Therapy
37. Psychological Factors Associated With Painful Versus Non-Painful HIV-Associated Sensory Neuropathy
38. Emerging Role and Characterization of Immunometabolism: Relevance to HIV Pathogenesis, Serious Non-AIDS Events, and a Cure
39. Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis
40. Diagnosing and Treating HIV-Associated Sensory Neuropathy: A Global Perspective
41. TNF Block Gene Variants Associate With Pain Intensity in Black Southern Africans With HIV-associated Sensory Neuropathy
42. Pharmacological treatment of painful HIV-associated sensory neuropathy
43. Brain Cell Reservoirs of Latent Virus in Presymptomatic HIV-Infected Individuals
44. Role of TNF block genetic variants in HIV-associated sensory neuropathy in black Southern Africans
45. First Molecular Epidemiology Study of Mycobacterium tuberculosis in Kiribati
46. Analysis of a Previously Identified “Pain-Protective” Haplotype and Individual Polymorphisms in the GCH1 Gene in Africans With HIV-Associated Sensory Neuropathy
47. Plasma levels of JC virus are sensitivity and specific for detecting and predicting progressive multifocal leukoencephalopathy in HIV patients
48. HIV Neuropathy Risk Factors and Symptom Characterization in Stavudine-Exposed South Africans
49. Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
50. Mitochondrial dysfunction in CD4+lymphocytes from stavudine-treated HIV patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.